KUALA LUMPUR: Alpha IVF Group Bhd is targeting to operate a total of at least 15 facilities, covering Malaysia, Indonesia, China, the Philippines, and Singapore by the financial year ending May 31, 2027.
The fertility care specialist currently operates four full-fledged IVF centres across Malaysia and Singapore, along with two sales and representative offices in China.
For the next 12 months, Alpha IVF expects two additional IVF centres in Malaysia, two IVF centres in South East Asia and four satellite clinics in Indonesia will be operational, it said in a filing with Bursa Malaysia.
In the third quarter ended Feb 28 (3Q25), Alpha IVF posted a lower net profit of RM11.9mil, or earnings per share of 0.24, compared with RM13.6mil, or 0.30 sen in the year-ago quarter.
Revenue for the quarter stood at RM40.6mil against RM40.7mil posted last year.
In the nine months to Feb 28, the group posted a net profit of RM41.4mil, up 6.3% from RM38.9mil a year ago, while revenue rose 5% to RM126.8mil from RM120.8mil previously.
Alpha IVF attributed the improved performance primarily to continued growth in its foreign patient segment within its Malaysian operations during the period.
The growing foreign patient base underscores Alpha IVF Group’s strong regional presence and reputation for delivering world-class fertility care.
“As we move forward, our strategy remains consistent – to grow both organically via our existing centres and through regional expansion initiatives.
“We believe the steps we are taking to expand access to our fertility treatment services in the region will not only strengthen our regional presence but also deliver long-term value for our shareholders,” group managing director Datuk Dr Colin Lee Soon Soo said in a statement.
